Uwe Platzbecker

38.1k citations

543 papers · 11.3k indexed · 1 hit paper · h-index 54

Impact in

Hematology top 0.02%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
Genetics top 0.05%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hemoglobinopathies and Related Disorders
- Chronic Lymphocytic Leukemia Research

Papers in

Hematology 441
- Acute Myeloid Leukemia Research 352
- Hematopoietic Stem Cell Transplantation 111
- Chronic Myeloid Leukemia Treatments 70
- Multiple Myeloma Research and Treatments 50
Genetics 223
- Myeloproliferative Neoplasms: Diagnosis and Treatment 123
- Hemoglobinopathies and Related Disorders 65
- Chronic Lymphocytic Leukemia Research 47

Co-authors: Martin Bornhäuser Gerhard Ehninger Christian Thiede Markus Schaich Thomas Illmer Brigitte Mohr Martin Wermke Pierre Fenaux
Journals: Blood (190 papers)Leukemia (25 papers)Journal of Clinical Oncology (23 papers)Leukemia Research (22 papers)HemaSphere (22 papers)
Partner nations: Germany United States France

In The Last Decade

Uwe Platzbecker

507 papers receiving 11.2k citations

Hit Papers

align trajectories log scale

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis 2002 · 1.3k citations

Peers

Countries citing papers authored by Uwe Platzbecker

Since Specialization

Citations

This map shows the geographic impact of Uwe Platzbecker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uwe Platzbecker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uwe Platzbecker more than expected).

Fields of papers citing papers by Uwe Platzbecker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uwe Platzbecker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uwe Platzbecker. The network helps show where Uwe Platzbecker may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Uwe Platzbecker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Uwe Platzbecker Line = papers co-authored together Uwe Platzbecker links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Gemtuzumab ozogamicin plus midostaurin in combination with standard ‘7 + 3’ induction therapy in newly diagnosed AML: Results from the SAL‐MODULE phase I study British Journal of Haematology ·Christoph Röllig, Christoph Schliemann, Leo Ruhnke, Lars Fransecky, Sheng Jq, Maher Hanoun, Richard Noppeney, Kerstin Schäfer‐Eckart, Knut Wendelin, Jan‐Henrik Mikesch, Jan Moritz Middeke, Manja Reimann, V. G. Shokokh, Sven Zukunft, Martin Wermke, Hubert Serve, Uwe Platzbecker, Carsten Müller‐Tidow, Claudia D. Baldus, Martin Bornhäuser	2024	3
2	Comprehensive sequential genetic analysis delineating frequency, patterns, and prognostic impact of genomic dynamics in a real‐world cohort of patients with lower‐risk MDS HemaSphere ·Karol Ofiara, Christina Ganster, Sudhakara Reddy Puchhalapalli, Katayoon Shirneshan, Tashfain Ahmed, Elżbieta Brzuszkiewicz, Doris Steinemann, Maximilian Schieck, Catharina Müller‐Thomas, Stacy Topouzova, Friederike Braulke, Ulrich Germing, Katja Sockel, Ekaterina Balaian, Julie Schanz, Uwe Platzbecker, Katharina S. Götze, Detlef Haase	2024	1
3	Predicting Progression Events in Multiple Myeloma from Routine Blood Work Blood ·Runlong Ye, 有紀子岳川, Markus Kreuz, Uwe Platzbecker, Thomas Neumuth, Kristin Reiche, Louis A. Merillat, Maximilian Merz	2024	0
4	Quantifying NPM1 MRD in AML patients prior to allogeneic stem cell transplantation: Where to draw the line? HemaSphere ·Sebastian Schwind, Ойгул Асилбек Қизи Дуланбоева, Marius Bill, Juliane Grimm, Rowe Jackson, Zhou Lan-gui, Sakinah Ruhi Sya'bania, Tung Pham Thanh, Maximilian Merz, Georg‐Nikolaus Franke, Klaus H. Metzeler, Vladan Vučinić, Marco Herling, Uwe Platzbecker, Madlen Jentzsch	2024	2
5	Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee Blood ·Francesco Onida, Nico Gagelmann, Yves Chalandon, Guido Kobbe, Marie Robin, Argiris Symeonidis, Théo de Witte, Raphaël Itzykson, Madlen Jentzsch, Uwe Platzbecker, Valeria Santini, Guillermo Sanz, Christof Scheid, Éric Solary, Peter Valent, ACUÇENA GONÇALVES MOURA, Isabel Sánchez‐Ortega, Ibrahim Yakoub‐Agha, Lisa Pleyer	2024	8
6	First‐in‐human study of JNJ‐67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome Clinical and Translational Science ·Rupa Narayan, Ana Alfonso Piérola, William B. Donnellan, R.J. Zhu, Maher Abdul‐Hay, Uwe Platzbecker, Marion Subklewe, Tapan M. Kadia, Juan Manuel Alonso‐Domínguez, James McCloskey, 里红杰, Jerome Stanley Rogers, Fernandez-Sanz Lius, Mrs. Simran Jaggi, Monika Pinchasov, Brett Hiebert, 佑子南, Xiang Li, Zoe Perry, Tevfik Senocak	2024	14
7	A phase 1b/2 study of pivekimab sunirine (PVEK, IMGN632) in combination with venetoclax/azacitidine for patients with newly diagnosed CD123-positive acute myeloid leukemia. Journal of Clinical Oncology ·Naval Daver, Pau Montesinos, Jessica K. Altman, Anjali S. Advani, Eunice S. Wang, Sylvain Garciaz, Giovanni Martinelli, Gail J. Roboz, Roland B. Walter, Kebede H. Begna, Monia Lunghi, Uwe Platzbecker, Paresh Vyas, Patrick W. Burke, Antonio Curti, Daniel J. DeAngelo, Lauris Gastaud, Christoph Schliemann, Benjamin Oshrine, David A. Sallman	2024	1
8	Predictive biomarkers of response to the IRAK4/FLT3 inhibitor emavusertib in hematological malignancies. Journal of Clinical Oncology ·Klaus H. Metzeler, Uwe Platzbecker, Eric S. Winer, Amit Verma, Daniel J. DeAngelo, Mariano Severgnini, Gaurav S. Choudhary, 右文鈴木, Saniya Anjum Yadgeer, J.M Cancino, Dora Ferrari, Alyssa Masciarelli, Balhoff Matthew, Samantha M. Carlisle, David C. Nickle, Guillermo Garcia‐Manero	2024	1
9	Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study British Journal of Haematology ·Klaus Geißler, Zdeněk Kořı́stek, Teresa Bernal, Jan Novák, Gabriela Rodríguez‐Macías, Stephan Metzelder, Árpád Illés, Jiřı́ Mayer, Montserrat Arnán, Mary‐Margaret Keating, Xiao-Jun, Monia Lunghi, Nicola Stefano Fracchiolla, Uwe Platzbecker, Valeria Santini, Yuri Sano, Aram Oganesian, Harold Keer, Michael Lübbert	2024	8
10	Efficacy and safety results from the COMMANDS trial: A phase 3 study evaluating luspatercept vs epoetin alfa in erythropoiesis-stimulating agent (ESA)-naive transfusion-dependent (TD) patients (pts) with lower-risk myelodysplastic syndromes (LR-MDS). Journal of Clinical Oncology ·Guillermo Garcia‐Manero, Uwe Platzbecker, Valeria Santini, Amer M. Zeidan, Pierre Fenaux, Rami S. Komrokji, Jake Shortt, David Valcárcel, Anna Jonášová, Sophie Dimicoli‐Salazar, Ing Soo Tiong, Chien‐Chin Lin, Jiahui Li, Nathalie Weibel, 太郎宮崎, Jeevan K. Shetty, V. Raj Thaneeghavl, Carlo Finelli, Thomas Cluzeau, Matteo Giovanni Della Porta	2023	0
11	Long-term utilization and benefit of luspatercept in transfusion-dependent, erythropoiesis-stimulating agent-refractory or -intolerant patients with lower-risk myelodysplastic syndromes with ring sideroblasts Leukemia ·Uwe Platzbecker, Valeria Santini, Rami S. Komrokji, Amer M. Zeidan, Guillermo Garcia‐Manero, Rena Buckstein, Dimana Miteva, Nora Stigrot, A Phositlimpagul, Tiancong Hao, Yinzhi Lai, 石辉荣, 鈴木美枝子, J. Lee, 邢秋月, Pierre Fenaux	2023	7
12	Efficacy and Safety of Roxadustat for Treatment of Anemia in Patients with Lower-Risk Myelodysplastic Syndrome (LR-MDS) with Low Red Blood Cell (RBC) Transfusion Burden: Results of Phase III Matterhorn Study Blood ·Moshe Mittelman, David H. Henry, John A. Glaspy, Anıl Tombak, Rosemary Harrup, Krzysztof Mądry, James Garbanno, Uwe Platzbecker, Tyson Lee, Katharina Modelska	2023	3
13	Teclistamab impairs detection of BCMA CAR-T cells Blood Advances ·Keneni Dina Dibera, RMG Lopes, J. Seneca, Maik Friedrich, Maximilian Merz, Vladan Vučinić, Manuel Unger, Kristin Reiche, Miriam Alb, Michael Hudecek, A. D. Yoder, Stephan Fricke, Uwe Platzbecker, Ulrike Koehl, Ulrich Sack, Andreas Boldt, Sunna Hauschildt, Ronald L. Weiss	2023	4
14	Clinical Implications of the FLT3-ITD Allelic Ratio in Acute Myeloid Leukemia in the Context of an Allogeneic Stem Cell Transplantation Cancers ·Madlen Jentzsch, Ойгул Асилбек Қизи Дуланбоева, Sakinah Ruhi Sya'bania, Zhou Lan-gui, Rowe Jackson, Georg‐Nikolaus Franke, Vladan Vučinić, Uwe Platzbecker, Sebastian Schwind	2023	3
15	Long-term outcome of second allogeneic hematopoietic stem cell transplantation (HSCT2) for primary graft failure in patients with acute leukemia in remission: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation Bone Marrow Transplantation ·Arnon Nagler, Myriam Labopin, K Pathania, Alexander Kulagin, Andrea Velardi, Jaime Sanz, Hélène Labussière‐Wallet, Victoria Potter, Jürgen Kuball, Simona Sica, Е. Н. Паровичникова, Wolfgang Bethge, Natacha Maillard, Uwe Platzbecker, Friedrich Stölzel, Fabio Ciceri, Mohamad Mohty	2023	4
16	Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation Blood Cancer Journal ·Madlen Jentzsch, Ойгул Асилбек Қизи Дуланбоева, Rowe Jackson, Zhou Lan-gui, Sakinah Ruhi Sya'bania, Klaus H. Metzeler, Maximilian Merz, Vladan Vučinić, Georg‐Nikolaus Franke, Marco Herling, Uwe Platzbecker, Sebastian Schwind	2022	20
17	Inflammation and myeloid malignancy: quenching the flame Blood ·Ryan J. Stubbins, Uwe Platzbecker, Aly Karsan	2022	25
18	The EORTC QLU-C10D was more efficient in detecting clinical known group differences in myelodysplastic syndromes than the EQ-5D-3L Journal of Clinical Epidemiology ·Eva‐Maria Gamper, Francesco Cottone, Kathrin Sommer, Richard Norman, Madeleine King, Massimo Breccia, Giovanni Caocci, Andrea Patriarca, Giuseppe A. Palumbo, Reinhard Stauder, Pasquale Niscola, Uwe Platzbecker, Jo Caers, Marco Vignetti, Fabio Efficace	2021	20
19	A Phase 1b Study Evaluating the Safety and Efficacy of Venetoclax in Combination with Azacitidine in Treatment-Naïve Patients with Higher-Risk Myelodysplastic Syndrome Blood ·Andrew H. Wei, Jacqueline S. Garcia, Uma Borate, Chun Yew Fong, Maria R. Baer, Florian Nolte, Pierre Péterlin, Joseph G. Jurcic, Guillermo Garcia‐Manero, Wan‐Jen Hong, Uwe Platzbecker, Olatoyosi Odenike, Martin Dunbar, Ying Zhou, Jason G. Harb, 泰光小野原, Johannes Wolff, Meagan A. Jacoby	2019	39
20	MRI-Based Liver Iron Content Predicts for Nonrelapse Mortality in MDS and AML Patients Undergoing Allogeneic Stem Cell Transplantation Clinical Cancer Research ·Martin Wermke, Anne Schmidt, Jan Moritz Middeke, Katja Sockel, Malte von Bonin, Qiuzi Xu, Sabine Mair, Verena Plodeck, Michael Laniado, Günter Weiß, Johannes Schetelig, Gerhard Ehninger, Igor Theurl, Martin Bornhäuser, Uwe Platzbecker	2012	57

About Uwe Platzbecker

Uwe Platzbecker is a scholar working on Hematology, Genetics, Oncology, Immunology and Emergency Medicine, having authored 543 papers that have together received 11.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (352 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (123 papers), Hematopoietic Stem Cell Transplantation (111 papers), Chronic Myeloid Leukemia Treatments (70 papers), Hemoglobinopathies and Related Disorders (65 papers), Acute Lymphoblastic Leukemia research (65 papers), Multiple Myeloma Research and Treatments (50 papers) and Chronic Lymphocytic Leukemia Research (47 papers). The work is most often cited by research in Hematology (8.8k citations), Genetics (4.1k citations), Immunology (1.4k citations), Oncology (1.7k citations) and Transplantation (164 citations). Uwe Platzbecker has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Martin Bornhäuser, Gerhard Ehninger, Christian Thiede, Markus Schaich, Thomas Illmer, Brigitte Mohr, Martin Wermke, Pierre Fenaux, Aristoteles Giagounidis and Andreas Neubauer. Their work appears in journals such as Blood, Leukemia, Journal of Clinical Oncology, Leukemia Research and HemaSphere.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact